Indian CDSCO flags over 50 drugs as "not of standard quality", raising concerns about counterfeit medications.

The Indian government's CDSCO has flagged over 50 drugs as "not of standard quality," raising concerns about counterfeit medications among consumers. Major pharmaceutical companies, including Sun Pharma and Glenmark, deny responsibility, asserting that these drugs are spurious. While the CDSCO claims these NSQ drugs pose negligible risks, the Indian Pharmaceutical Alliance stresses the need to distinguish between NSQ and counterfeit drugs to protect the industry's reputation and public health.

September 29, 2024
11 Articles